Defining the Optimal Regimen for Stage III Colon Cancer: Concerns with Study Design

Authors :: Gurkan Guner
Oktay Halit Aktepe
Deniz Can Guven
Zafer Arik
Burak Yasin Aktas
Hakan Taban
Source :: Clinical colorectal cancer. 19(3)
Publication Year :: 2019

Subjects :: Oncology
medicine.medical_specialty
business.industry
Colorectal cancer
Gastroenterology
MEDLINE
Leucovorin
medicine.disease
Stage III Colon Cancer
Oxaliplatin
Regimen
Chemotherapy, Adjuvant
Internal medicine
Colonic Neoplasms
medicine
Humans
business
Tegafur

Tools